BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18260640)

  • 21. Structure and apoptotic function of p73.
    Yoon MK; Ha JH; Lee MS; Chi SW
    BMB Rep; 2015 Feb; 48(2):81-90. PubMed ID: 25441426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
    Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
    Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of functions within the p53/p63/p73 family.
    De Laurenzi V; Melino G
    Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
    Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional interplay between MDM2, p63/p73 and mutant p53.
    Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
    Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation.
    Burge S; Teufel DP; Townsley FM; Freund SM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3142-7. PubMed ID: 19218448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax.
    Patel S; George R; Autore F; Fraternali F; Ladbury JE; Nikolova PV
    Nucleic Acids Res; 2008 Sep; 36(16):5139-51. PubMed ID: 18676979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution structure and binding specificity of the p63 DNA binding domain.
    Enthart A; Klein C; Dehner A; Coles M; Gemmecker G; Kessler H; Hagn F
    Sci Rep; 2016 May; 6():26707. PubMed ID: 27225672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One billion years of p53/p63/p73 evolution.
    Belyi VA; Levine AJ
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17609-10. PubMed ID: 19826090
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis.
    Tozluoğlu M; Karaca E; Haliloglu T; Nussinov R
    Nucleic Acids Res; 2008 Sep; 36(15):5033-49. PubMed ID: 18660513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The functional domains in p53 family proteins exhibit both common and distinct properties.
    Harms KL; Chen X
    Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
    Robinson RA; Lu X; Jones EY; Siebold C
    Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Backbone resonance assignments of the human p73 DNA binding domain.
    Cino EA; Soares IN; Freitas MS; Silva JL
    Biomol NMR Assign; 2016 Apr; 10(1):49-51. PubMed ID: 26294377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.